Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Reserpine Reversal Response by Iproniazid: a Dose-dependent Phenomenon

Nature volume 202, pages 604–605 (1964)Cite this article

Abstract

THE modification of the cardiovascular response to reserpine has been accomplished, by the pretreatment of animals with various pharmacological agents. Thus, the administration of ganglionic blocking agents1, cocaine2, and imipramine3 has resulted in the appearance of a vasopressor response on the intravenous injections of reserpine4. Pretreatment with the irreversible inhibitors of monoamine oxidase (MAO) also has resulted in the reversal of the usual hypotensive action of reserpine. In these instances it has been presumed that this modified response was the result of an increased concentration of circulating catecholamines due to their release by reserpine and their protection from destruction by the presence of the MAO inhibitors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Maxwell, R. A., Ross, S. D., Plummer, A. J., and Siggs, E. B., J. Pharmacol. Exp. Therap., 119, 69 (1957).

    CAS  Google Scholar 

  2. Horita, A., J. Pharmacol. Exp. Therap., 122, 474 (1958).

    CAS  Google Scholar 

  3. Osborne, M., Arch. Int. Pharmacodyn., 138, 492 (1962).

    CAS  Google Scholar 

  4. Chessin, M., Dubnick, B., Lesson, G., and Scott, C. C., J. Pharmacol. Exp. Therap., 119, 453 (1960).

    Google Scholar 

  5. Goldberg, N. D., and Shideman, F. E., J. Pharmacol. Exp. Therap., 136, 142 (1962).

    CAS  Google Scholar 

  6. Shoepke, H. G., and Wiegand, R. G., Ann. N.Y. Acad. Sci., 107, 924 (1963).

    Article  ADS  Google Scholar 

  7. Kroneberg, G., and Schümann, H. J., Arch. Exp. Path. Pharmakol., 239, 29 (1960).

    CAS  Google Scholar 

  8. Pletscher, A., Gey, K. K., and Zeller, P., Prog. Drug Res., 2, 485 (1960).

    Google Scholar 

  9. Axelrod, J., Hertting, G., and Patrick, R. W., J. Pharmacol. Exp. Therap., 134, 325 (1961).

    CAS  Google Scholar 

  10. Gessa, G. L., Cuenca, E., and Costa, E., Ann. N.Y. Acad. Sci., 107, 935 (1963).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, School of Medicine, University of Washington, Seattle

    L. D. HULL & A. HORITA

Authors
  1. L. D. HULL
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. HORITA
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

HULL, L., HORITA, A. Reserpine Reversal Response by Iproniazid: a Dose-dependent Phenomenon. Nature 202, 604–605 (1964). https://doi.org/10.1038/202604a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/202604a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing